Media contact: Savannah Koplon, skoplon@uab.edu
Michael Saag, M.D.
Division of Infectious Diseases
Areas of expertise:
- HIV/AIDS infection control
- Antiretroviral therapy
- HIV/AIDS research
- Hepatitis C diagnosis and therapy
More than 30 years ago, Saag founded UAB’s 1917 Clinic with a mission to provide compassionate and comprehensive health care linked to cutting edge research for persons living with HIV infection. Since then, the clinic has provided comprehensive core medical and social services, as well as, dental and mental health services to its patients.
Saag has published more than 400 articles in peer reviewed journals, including the first description of the quasispecies nature of HIV (Nature, 1988), first use of viral load in clinical practice (Science, 1993), the first description of the rapid dynamics of viral replication (Nature, 1995), the first guidelines for use of viral load in practice (Nature Medicine, 1996), the first proof of concept of fusion inhibition as a therapeutic option (Nature Medicine, 1998), and directed the ‘first in-patient’ studies of 7 of the 25 antiretroviral drugs currently on the market (including indinavir, efavirenz, abacavir, and enfuvirtide).
Video interview:
Media coverage:
- Obesity, not wasting, top worry for HIV patients, NBC News
- Doctors fighting AIDS worry about 'late failures,' Wall Street Journal
- New HIV/AIDS plan calls for reducing infections, NPR
- The Latest: Governor says California getting a grip on virus, Daily Mail
- Has the coronavirus ruined the high-five?, ESPN
- Federal program cuts disparities in HIV/AIDS, Reuters
- Most boomers infected with liver-damaging hepatitis C virus do not know it, USA Today
- HIV care system is getting swamped, WebMD
- Electronic network to pool information about HIV, The New York Times
- Preventing HIV transmission: who pays? ABC News
- What it's like to be infected with coronavirus, The Washington Post